BCL3 and malignant peritoneal mesothelioma: Ultimately, in vivo validation of the role of PD-1 and BCL3 in CD8+ T cells can be studied using malignant peritoneal mesothelioma mouse models through silencing of PD1 and/or BCL3 and measuring the functional activity of CD8+ T cells.